CIBC Private Wealth Group
RLAY icon

CIBC Private Wealth Group’s Relay Therapeutics RLAY Stock Holding History

CIBC Private Wealth Group’s Portfolio RLAY Stock Details RLAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$5.75K Buy
+680
New +$4.85K ﹤0.01% 2589

Other funds holding RLAY

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CIBC Private Wealth Group's RLAY Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Relay Therapeutics (RLAY) in Q4 2025: 680 shares worth $5.75K. The stake represents ﹤0.01% of the portfolio and ranks #2589 among its holdings.

227 funds tracked by Wall St. Rank hold RLAY as of Q4 2025.

  • CIBC Private Wealth Group held 680 shares of Relay Therapeutics worth $5.75K as of Q4 2025.
  • Relay Therapeutics was a new CIBC Private Wealth Group position in Q4 2025.
  • Relay Therapeutics made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2589 holding.
  • 227 funds tracked by Wall St. Rank held Relay Therapeutics as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.